Abstract
Background:
Aegle marmelos (commonly known as Bael, golden apple) was formerly described to have anti-hyperglycemic activity. The present study aimed to explore the possible effects, in depth, of A. marmelos extracts on carbohydrate absorption, glucose utilization, and α-amylase inhibition and insulin content in pancreases of type 2 diabetic rats.
Methods:
This research begins with fasting blood glucose and oral glucose tolerance test (OGTT) to evaluate the primary anti-hyperglycemic effect in chemically induced type 2 diabetic rats. Furthermore, the plasma insulin concentration and serum glucose level were studied, which include measuring the sucrose content in six different segments of the gastrointestinal (GI) tract of the rats following oral sucrose feeding. An in situ, perfused, intestinal model in rats and glucose-fiber binding assay were conducted to find the effects of A. marmelos extracts on glucose absorption. Extract effects on carbohydrate breakdown, intestinal disaccharidase enzyme activity, and α-amylase inhibition were assessed. Effect on GI motility was evaluated using BaSO4 milk traverse test.
Results:
Treatment of extracts suppressed blood glucose elevation after oral sucrose (2.5 g/kg) administration and significantly (p<0.05) improved oral glucose tolerance in type 2 diabetic rats. Aegle marmelos extracts showed remarkable (p<0.05) changes in plasma insulin secretion at 30 min and 60 min, respectively. A noticeable reduction in glucose absorption was observed in the in situ perfused rat intestinal model at two different doses (250 and 500 mg/kg). The extract was also found to inhibit the action of both α-amylase and intestinal disaccharidase enzyme, and this study was affirmed again by the sucrose malabsorption test, where sucrose digestion was inhibited throughout the length of the GI tract. During this chronic study, body mass of rats became normal and their polydipsic and polyphagic conditions were ameliorated also.
Conclusions:
The findings demonstrate that anti-hyperglycemic activity of A. marmelos is mediated by the inhibition of carbohydrate digestion and absorption, and improvement of insulin action to uptake glucose in peripheral tissue. Additional study is required to correlate A. marmelos extracts’ specific mechanism of glucose-fiber binding capacity and glucose transporters.
Acknowledgments
The authors are grateful to Pharmacology Lab Officer Ms. Junaida Khaleque of North South University for their support and collaboration that made this work possible.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted article and approved submission. JMAH and PA participated in experiments, study design, and article preparation. PA and SJ carried out the study design, participated in experiments, article preparation, and statistical analysis. JMAH – supervising and directing the project. SBA, GMM, SA, SMNH, SMH, and RRT participated in experiments. JMAH and PA checked the grammatical mistakes and corrected the final article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. World Health Organization. Global health estimates: deaths by cause, age, sex and country, 2000–2012. Geneva: WHO, 2014.Search in Google Scholar
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.10.1371/journal.pmed.0030442Search in Google Scholar PubMed PubMed Central
3. Clement S. Diabetes self-management education. Diabetes Care 1995;18:1204–14.10.2337/diacare.18.8.1204Search in Google Scholar PubMed
4. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, et al. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabetic Med 2005;22:1379–85.10.1111/j.1464-5491.2005.01644.xSearch in Google Scholar PubMed
5. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989;12:553–64.10.2337/diacare.12.8.553Search in Google Scholar PubMed
6. Alam M, Siddiqui M, Husain W. Treatment of diabetes through herbal drugs in rural India. Fitoterapia 1990;61:240–2.Search in Google Scholar
7. Sabu MC, Kuttan R. Antidiabetic activity of A. mermelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol 2004;48:81–8.Search in Google Scholar
8. Bhavani R, Rajeshkumar S. Anti-hyperglycemic activity of alcoholic leaf extract of Agele marmelos (linn.) on alloxane induced diabetic rats. Int J Pharma Sci Res 2014;5:56–62.Search in Google Scholar
9. Vijaya C, Ramanathan M, Suresh B. Lipid lowering activity of ethanolic extracts of leaves of Agele marmelos (linn.) hyperlipidemic model of Wister Albino rats. Indian J Exp Biol 2009;47:182–5.Search in Google Scholar
10. Sachdewa A1, Raina D, Srivastava AK, Khemani LD. Effect of Aegle marmelos and Hibiscus rosa sinensis leaf extract on glucose tolerance in glucose induced hyperglycemic rats (Charles foster). J Environ Biol 2001;22:53–7.Search in Google Scholar
11. Narendhirakannan RT, Subramanian S. Biochemical evaluation of the protective effect of Aegle marmelos (L.), Corr. leaf extract on tissue antioxidant defense system and histological changes of pancreatic β-cells in streptozotocin-induced diabetic rats. Drug Chem Toxicol 2010;33:120–30.10.3109/01480540903203984Search in Google Scholar PubMed
12. Kumar V, Ahmed D, Verma A, Anwar F, Ali M, et al. Umbelliferone β-D-galactopyranoside from Aeglemarmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity. BMC Complement Alt Med 2013;13:273.10.1186/1472-6882-13-273Search in Google Scholar PubMed PubMed Central
13. Sharma B, Satapathi SK, Roy P. Hypoglycemic and hypolipidemic effect of Aegle marmelos (L.) leaf extract on streptozotocin induced diabetic mice. Int J Pharmacol 2007;3:444–52.10.3923/ijp.2007.444.452Search in Google Scholar
14. Ismail MY. Clinical evaluation of antidiabetic activity of trigonella seeds and aegle marmelos leaves. World App Sci J 2009;7:1231–4.Search in Google Scholar
15. Upadhya S, Shanbhag KK, Suneetha G, Naidu MB, Upadhya S. A study fo hypoglycemic and anti-oxidant activity of Aegle marmelos in alloxen induced diabetic rats. Indian J Physiol Pharmacol 2004;48:476–80.Search in Google Scholar
16. Bayne K. Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist 1996;39:199–208.Search in Google Scholar
17. Lenzen S. The mechanisms of alloxan and streptozotocin induced diabetes. Diabetologia 2008;51:216–26.10.1007/s00125-007-0886-7Search in Google Scholar PubMed
18. Moniruzzaman M, Rokeya B, Ahmed S, Bhowmik A, Khalil I, et al. In vitro antioxidant effects of Aloe barbadensis Miller extracts and the potential role of these extractsas antidiabetic and antilipidemic agents on streptozotocininduced type 2 diabetic model rats. Molecules 2012;17:12851–67.10.3390/molecules171112851Search in Google Scholar PubMed PubMed Central
19. Trinder P. Enzymatic colorimetric method for estimation of glucose test (GOD-PAP method), uric acid and phosohlipids. Ann Clin Biochem 1969;6:25.Search in Google Scholar
20. Hannan JM, Ali L, Rokeya B, Khaleque J, Akhter M, et al. Soluble dietary fibre fraction of Trigonellafoenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion andabsorption, and enhancing insulin action. Br J Nutr 2007;97:514–21.10.1017/S0007114507657869Search in Google Scholar PubMed
21. Van der Vies J. Two methods for the determination of glycogen in liver. Biochem J 1954;57:410.10.1042/bj0570410Search in Google Scholar
22. Swintosky JV, Pogonowska-Wala E. The in situ rats gut technique. Pharma Int 1982;3:163–7.Search in Google Scholar
23. Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, et al. An α-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Prac 1995;28:81–7.10.1016/0168-8227(95)01065-LSearch in Google Scholar
24. Chatterjee T. Handbook of laboratory mice and rats. Jadavpur University: Kolkata, India, 1993.Search in Google Scholar
25. Ou S, Kwok KC, Li Y, Fu L. In vitro study of possible role of dietary fiber in lowering postprandial serum glucose. J Agri Food Chem 2001;49:1026–9.10.1021/jf000574nSearch in Google Scholar
26. Chau C-F, Huang Y-L, Lee M-H. In vitro hypoglycemic effects of different insoluble fiber-rich fractions prepared from the peel of Citrus sinensis L.cv. Liucheng. J Agric Food Chem 2003;51:6623–6.10.1021/jf034449ySearch in Google Scholar
27. Brownlee M. The pathobiology of diabetic complications a unifying mechanism. Diabetes 2005;54:1615–25.10.2337/diabetes.54.6.1615Search in Google Scholar
28. Turner R, Holman R, Cull C, Stratton I, Matthews D, et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.10.1016/S0140-6736(98)07019-6Search in Google Scholar
29. Heilig C, Concepcion L, Riser B, Freytag S, Zhu M, et al. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995;96:1802.10.1172/JCI118226Search in Google Scholar
30. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, et al. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993;42:80–9.10.2337/diab.42.1.80Search in Google Scholar
31. Haller H. Postprandial glucose and vascular disease. Diabetic Med 1997;14:S50–6.10.1002/(SICI)1096-9136(199708)14:3+<S50::AID-DIA445>3.0.CO;2-1Search in Google Scholar
32. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859–6.10.2337/diabetes.47.6.859Search in Google Scholar
33. Ceriello A, Taboga C, Tonutti L, Giacomello R, Stel L, et al. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia 1996;39:469–73.10.1007/BF00400679Search in Google Scholar
34. Thornalley PJ. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metabol London 1996;3:149–66.Search in Google Scholar
35. Krentz AJ, Bailey CJ. Oral antidiabetic agents. Drugs 2005;65:385–411.10.2165/00003495-200565030-00005Search in Google Scholar
36. Jenkins D, Wolever T, Leeds AR, Gassull MA, Haisman P, et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978;1:1392.10.1136/bmj.1.6124.1392Search in Google Scholar
37. Groop P-H, Aro A, Stenman S, Groop L. Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1993;58:513–8.10.1093/ajcn/58.4.513Search in Google Scholar
38. Edwards C, Johnson I, Read N. Do viscous polysaccharides slow absorption by inhibiting diffusion or convection? European J Clin Nutr 1988;42:307.Search in Google Scholar
39. Burkitt D, Walker A, Painter NS. Effect of dietary fibre on stools and transit-times, and its role in the causation of disease. Lancet 1972;300:1408–11.10.1016/S0140-6736(72)92974-1Search in Google Scholar
40. Holgate A, Read N. Relationship between small bowel transit time and absorption of a solid meal influence of metoclopramide, magnesium sulfate, and lactulose. Dig Dis Sci 1983;28:812–9.10.1007/BF01296904Search in Google Scholar PubMed
41. Reynell P, Spray G. The simultaneous measurement of absorption and transit in the gastro-intestinal tract of the rat. J Physiol 1956;131:452–62.10.1113/jphysiol.1956.sp005474Search in Google Scholar PubMed PubMed Central
42. Crane RK. The physiology of the intestinal absorption of sugars. Physiol Eff Food Carbohyd 1975;1–19.10.1021/bk-1975-0015.ch001Search in Google Scholar
43. Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, Sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia a nested case-control analysis. Diabetes Care 2008;31:2086–91.10.2337/dc08-1171Search in Google Scholar PubMed PubMed Central
44. Dhankhar S, Ruhil S, Balhara M, Dhankhar S, Chhillar AK. Aegle marmelos (Linn.) Correa: a potential source of Phytomedicine. J Med Plant Res 2011;5:1497–507.Search in Google Scholar
45. Kruawan K, Kangsadalampai K. Antioxidant activity phenolic compound contents and antimutagenic activity of some water extract of herbs. Thai J Pharma Sci 2006;30:1–47.Search in Google Scholar
46. Jagetia GC, Venkatesh P, Baliga MS. Fruit extract of Aegle marmelos protects mice against radiation – induced lethality. Integr Cancer Ther 2004;3:323.10.1177/1534735404270641Search in Google Scholar PubMed
47. Farshchi A, Ghiasi G, Farshchi S, Ghobadi AT. The effect of chronic administration of aegle marmelos seed extract on learning and memory in diabetic rats. Iran J Basic Med Sci 2011;14:42–8.Search in Google Scholar
48. Arumugam S, Kavimani S, Kadalmani B, Ahmed AB, Akbarsha MA, et al. Antidiabetic activity of leaf and callus extracts of Aeglemarmelos in rabbit. Sci Asia 2008;34:317–21.10.2306/scienceasia1513-1874.2008.34.317Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
